Tatva Chintan shareholders approve all resolutions at 29th AGM

Tatva Chintan Pharma Chem Limited announced that all twelve resolutions proposed at its 29th Annual General Meeting (AGM) on September 26, 2025, were passed with the requisite majority. The AGM, held via Video Conferencing / Other Audio Visual Means, concluded at 4:36 PM IST, having commenced at 4:00 PM IST. The record date for voting was September 19, 2025, with a total of 74,978 shareholders on record.

Key ordinary business resolutions included the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025, both receiving overwhelming approval with 99.9996% of votes in favor. Shareholders also approved the dividend declaration for the financial year ended March 31, 2025, with 99.9998% approval.

Special business resolutions, including the re-appointment of directors Mr. Ajaykumar Mansukhlal Patel, Mr. Chintan Nitinkumar Shah, Mr. Shekhar Rasiklal Somani, Mr. Subhash Ambubhai Patel, and Mrs. Avani Rajesh Umatt, were also passed with high approval rates, predominantly above 99.9%. The ratification of remuneration payable to the cost auditors for the financial year 2025-26 also passed with 99.9996% of votes in favor.